PubMed

Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.

Shafran SD, Mashinter LD, Phillips P, Lalonde RG, Gill MJ, Walmsley SL, Toma E, Conway B, Fong IW, Rachlis AR, Williams KE, Garber GE, Schlech WF, Smaill F, Pradier C.

Ann Intern Med. 2002 Nov 5;137(9):734-7.PMID: 12416943 [PubMed - indexed for MEDLINE]Related articlesFree article

Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection.

Liao CH, Chen MY, Hsieh SM, Sheng WH, Hung CC, Chang SC.

J Microbiol Immunol Infect. 2004 Feb;37(1):50-6.PMID: 15060688 [PubMed - indexed for MEDLINE]Related articlesFree article

Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

Currier JS, Williams PL, Koletar SL, Cohn SE, Murphy RL, Heald AE, Hafner R, Bassily EL, Lederman HM, Knirsch C, Benson CA, Valdez H, Aberg JA, McCutchan JA.

Ann Intern Med. 2000 Oct 3;133(7):493-503.PMID: 11015162 [PubMed - indexed for MEDLINE]Related articlesFree article

[AIDS-related Mycobacterium avium infection dissemination in a patient with endobronchial lesions associated with immune reconstitution inflammatory syndrome]

Ogawa E, Murata M, Ohnishi H, Tatsukawa M, Sawayama Y, Furusyo N, Hayashi J.

Kansenshogaku Zasshi. 2008 Jul;82(4):341-6. Japanese. PMID: 18697487 [PubMed - indexed for MEDLINE]Related articles

Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.

Rossi M, Flepp M, Telenti A, Schiffer V, Egloff N, Bucher H, Vernazza P, Bernasconi E, Weber R, Rickenbach M, Furrer H; Swiss HIV Cohort Study.

Swiss Med Wkly. 2001 Aug 11;131(31-32):471-7.PMID: 11641970 [PubMed - indexed for MEDLINE]Related articlesFree article

Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents.

Cinti SK, Kaul DR, Sax PE, Crane LR, Kazanjian PH.

Clin Infect Dis. 2000 Mar;30(3):511-4.PMID: 10722436 [PubMed - indexed for MEDLINE]Related articles

Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.

Lazaro E, Coureau G, Guedj J, Blanco P, Pellegrin I, Commenges D, Dabis F, Moreau JF, Pellegrin JL, Thiébaut R; ANRS Co3 Aquitaine Cohort.

Antivir Ther. 2006;11(3):343-50.PMID: 16759051 [PubMed - indexed for MEDLINE]Related articlesFree article

Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.

Karakousis PC, Moore RD, Chaisson RE.

Lancet Infect Dis. 2004 Sep;4(9):557-65. Review.PMID: 15336223 [PubMed - indexed for MEDLINE]Related articles

Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy.

Aberg JA, Yajko DM, Jacobson MA.

J Infect Dis. 1998 Nov;178(5):1446-9.PMID: 9780266 [PubMed - indexed for MEDLINE]Related articles

Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.

Kirk O, Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C, Wit FW, Ledergerber B, Lundgren JD, Furrer H; European HIV Cohorts.

Ann Intern Med. 2002 Aug 20;137(4):239-50.PMID: 12186514 [PubMed - indexed for MEDLINE]Related articlesFree article

Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?

Lange CG, Woolley IJ, Brodt RH.

Drugs. 2004;64(7):679-92. Review.PMID: 15025543 [PubMed - indexed for MEDLINE]Related articles

Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.

Zeller V, Truffot C, Agher R, Bossi P, Tubiana R, Caumes E, Jouan M, Bricaire F, Katlama C.

Clin Infect Dis. 2002 Mar 1;34(5):662-7. Epub 2002 Jan 24.PMID: 11810599 [PubMed - indexed for MEDLINE]Related articles

Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.

El-Sadr WM, Burman WJ, Grant LB, Matts JP, Hafner R, Crane L, Zeh D, Gallagher B, Mannheimer SB, Martinez A, Gordin F.

N Engl J Med. 2000 Apr 13;342(15):1085-92.PMID: 10766581 [PubMed - indexed for MEDLINE]Related articlesFree article

[Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment]

Pavie J, Porcher R, Fournier S, André F, Tournoux C, Palmer P, Rabian C, Jean-Michel M.

Presse Med. 2005 Jun 4;34(10 Suppl):1S8-13. French. PMID: 16025661 [PubMed - indexed for MEDLINE]Related articles

Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection.

Murray R, Mallal S, Heath C, French M.

Eur J Clin Microbiol Infect Dis. 2001 Mar;20(3):199-201.PMID: 11347672 [PubMed - indexed for MEDLINE]Related articles

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.

Soriano V, Dona C, Rodríguez-Rosado R, Barreiro P, González-Lahoz J.

AIDS. 2000 Mar 10;14(4):383-6.PMID: 10770540 [PubMed - indexed for MEDLINE]Related articles

A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team.

Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani FJ, Lennox JL, Dube MP, MacGregor RR, Currier JS; AIDS Clinical Trial Group 393 Study Team.

J Infect Dis. 2003 Apr 1;187(7):1046-52. Epub 2003 Mar 14. Erratum in: J Infect Dis. 2003 Apr 15;187(8):1346. PMID: 12660918 [PubMed - indexed for MEDLINE]Related articles

Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study.

Furrer H, Telenti A, Rossi M, Ledergerber B.

AIDS. 2000 Jul 7;14(10):1409-12.PMID: 10930156 [PubMed - indexed for MEDLINE]Related articles

Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study.

Pechère M, Opravil M, Wald A, Chave JP, Bessesen M, Sievers A, Hein R, von Overbeck J, Clark RA, Tortoli E, et al.

Arch Intern Med. 1995 Feb 27;155(4):400-4.PMID: 7848023 [PubMed - indexed for MEDLINE]Related articles

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.

Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM, Miedema F, Reiss P.

AIDS. 1999 Feb 4;13(2):177-84.PMID: 10202823 [PubMed - indexed for MEDLINE]Related articles